收藏切换
Longitudinal Characterization of Giant ANK2-Depleted Monkeys Suggests Neurodevelopmental-Disorder-Like Phenotypes
收藏切换
PDF
Hong-Di Huang1, 2, 3, Yun-Chao Ji2, Long Zhang1, 2, 3, Min Xu1, 2, 3, Yicheng Qiao4, 5, Chen-Yao Li1, 2, 3, Hui-Hen Xie2, Yu Li1, 2, Bao-Lin Zhang1, 2, 6, Ming-Hao Qiu2, Ya-Li Zhang1, 2, 3, Xiao-Mei Yu1, 2, Yun-Bing Zhang2, Yun Wang2, Qiong Wang2, Yi-Jiang Li2, Long-Bao Lv1, 2, 3, Xing-Xu Huang7, Bing-Yu Mao1, 2, 3, 8, Dong-Dong Wu1, 2, 3, 8, Ping Zheng1, 2, 3, 8, *, Ning Liu4, 5, *, Jian-Hong Wang1, 2, 3, *, Yong-Gang Yao1, 2, 3, 8, *
Research. Vol 9 Article ID 1424
Less
收藏切换
Research. Vol 9 Article ID 1424
• RESEARCH ARTICLE •
Longitudinal Characterization of Giant ANK2-Depleted Monkeys Suggests Neurodevelopmental-Disorder-Like Phenotypes
Full
Hong-Di Huang1, 2, 3, Yun-Chao Ji2, Long Zhang1, 2, 3, Min Xu1, 2, 3, Yicheng Qiao4, 5, Chen-Yao Li1, 2, 3, Hui-Hen Xie2, Yu Li1, 2, Bao-Lin Zhang1, 2, 6, Ming-Hao Qiu2, Ya-Li Zhang1, 2, 3, Xiao-Mei Yu1, 2, Yun-Bing Zhang2, Yun Wang2, Qiong Wang2, Yi-Jiang Li2, Long-Bao Lv1, 2, 3, Xing-Xu Huang7, Bing-Yu Mao1, 2, 3, 8, Dong-Dong Wu1, 2, 3, 8, Ping Zheng1, 2, 3, 8, *, Ning Liu4, 5, *, Jian-Hong Wang1, 2, 3, *, Yong-Gang Yao1, 2, 3, 8, *
Affiliations
  • 1State Key Laboratory of Genetic Evolution and Animal Models, Yunnan Key Laboratory of Animal Models and Human Disease Mechanisms, and Yunnan Engineering Center on Brain Disease Models, Kunming, Yunnan 650204, China.
  • 2National Research Facility for Phenotypic & Genetic Analysis of Model Animals (Primate Facility) and National Resource Center for Non-Human Primates, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650107, China.
  • 3Kunming College of Life Sciences, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China.
  • 4State Key Laboratory of Cognitive Science and Mental Health, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • 5College of Life Sciences, University of Chinese Academy of Sciences, Beijing 101408, China.
  • 6Yunnan Key Laboratory of Biodiversity Information, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650201, China.
  • 7School of Life Science and Technology, Shanghai Tech University, Shanghai, China.
  • 8KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650204, China.
Published: 2026-09-20 doi: 10.34133/research.1424
Outline
收藏切换

The ANK2 gene mutations are marked risk factors for autism spectrum disorder, one of the neurodevelopmental disorders (NDDs) that often extends into adulthood and has a complex etiology involving genetic and environmental factors. ANK2 encodes 2 major isoforms, AnkB-220 (220-kDa isoform of ankyrin-B) and giant AnkB-440. We previously generated a targeted knockout (KO) of giant AnkB-440 in 2 cynomolgus and 2 rhesus monkeys. While no autism-spectrum-disorder-like phenotypes were observed during infancy, we found marked brain volume loss. In this study, we conducted a longitudinal multimodal study in these giant ANK2 KO monkeys during adolescent and young adulthood. Behavioral results from these giant ANK2 KO monkeys revealed increased locomotor activity, deficient cognition (including working memory, cognitive flexibility, and operant lever-press learning), and impaired emotional regulation and social interaction. Furthermore, the giant ANK2 KO monkeys exhibited persistent structural and functional brain abnormalities, up-regulation of brain triglyceride and glycerophospholipids, and peripheral blood transcriptome signatures of immune dysregulation, which may be related to their behavioral alternations. These observations suggest that giant ANK2 depletion in non-human primates phenocopies aspects of behavioral, neural, and molecular features characteristic of NDDs. This study provides an in-depth exploratory longitudinal characterization of giant ANK2 functions in primate brains, which may contribute to translational research on NDDs.

Hong-Di Huang, Yun-Chao Ji, Long Zhang, Min Xu, Yicheng Qiao, Chen-Yao Li, Hui-Hen Xie, Yu Li, Bao-Lin Zhang, Ming-Hao Qiu, Ya-Li Zhang, Xiao-Mei Yu, Yun-Bing Zhang, Yun Wang, Qiong Wang, Yi-Jiang Li, Long-Bao Lv, Xing-Xu Huang, Bing-Yu Mao, Dong-Dong Wu, Ping Zheng, Ning Liu, Jian-Hong Wang, Yong-Gang Yao. Longitudinal Characterization of Giant ANK2-Depleted Monkeys Suggests Neurodevelopmental-Disorder-Like Phenotypes[J]. Research, 2026 , 9 (9) : 1424 - . DOI: 10.34133/research.1424
Human neurodevelopment is a prolonged process extending into adulthood. Abnormalities during this period can lead to neurodevelopmental disorders (NDDs), conditions that originate in development and result in deficits in personal and social functioning [1–3]. Common NDDs include autism spectrum disorder (ASD), intellectual disability (ID), attention-deficit/hyperactivity disorder, and motor disorders. Schizophrenia and neurological malformations are also proposed to belong to this spectrum [1–3]. The etiology of NDDs is complex, involving genetic and environmental factors [4–6].
The ANK2 gene is crucial for neural development, playing a role in axonal guidance, neural circuit assembly [7–12], and stability of inhibitory synapses [13]. It encodes AnkB (ankyrin-B), which has 2 major isoforms: The widely expressed 220-kDa protein (AnkB-220) is found to function in dendritic spines, and the neuron-specific 440-kDa protein (giant AnkB-440) predominates in unmyelinated axons [12,14]. AnkB mutations are linked to peripheral pathologies, such as cardiac dysfunction, epilepsy, and metabolic syndrome [15–17]. Importantly, de novo ANK2 mutations are marked risk factors for ASD [18–21] and are enriched in NDD populations presenting with developmental delay and ID [22–24], supporting ANK2’s associations with broader NDDs [22]. The giant ANK2 isoform (AnkB-440) encompasses the full AnkB-220 sequence along with additional exons, suggesting that mutations in AnkB-220 could also impact the giant ANK2 isoform. To date, however, researches have focused almost exclusively on mutations within the AnkB-220 sequence, leaving the functions of giant ANK2 in the nervous system largely unexplored.
Previous studies using rodents revealed AnkB’s role in spine regulation, neuritogenesis, and axonal transport and development [10,12,14]. ANK2 knockout (KO) mice showed disrupted neurogenesis and neuronal migration, axon tract loss, enlarged lateral ventricles [7,25,26]. Mice with a mutation or deficiency in giant AnkB-440 exhibited ASD-like behaviors and aberrant structural connectivity probably due to the gain of axon branching [10]. However, translating findings from mice to humans is challenging because of significant interspecies differences in genetics and neurobiology [27]. For example, SHANK3 or PINK1 mutant non-human primates (NHPs) exhibited neuronal development disruptions not seen in mice [28,29], highlighting the need for NHPs in neurological research, which share the closest phylogenetic relationship to humans and display similar brain developmental trajectories and architectural features [30–33]. Furthermore, the symptoms of NDDs typically emerge and reach full manifestation during late childhood or adolescence, a developmental period that is markedly compressed in rodents yet significantly extended in primates. Consequently, longitudinal studies in NHPs are indispensable for accurately delineating the complete disease course.
Previously, we generated a targeted KO of giant ANK2 (AnkB-440) in rhesus monkeys and cynomolgus monkeys [11] to better model human ASD or other NDDs. Surprisingly, we observed pronounced brain volume loss in these KO monkeys. However, behavioral assessments in infancy revealed no significant differences in social interaction, exploratory or stereotypical behaviors, sleep, or activity levels between KO and control monkeys. These phenotypes were dramatically different from those of mice [10]. Although early brain structural abnormalities are clearly evident, the questions of particular relevance in NHPs remain unknown: whether these deficits persist or progressively worsen over time and how giant ANK2 depletion affects the brain during adolescence and young adulthood.
Guided by our infantile observations, we speculated that giant ANK2 KO would drive a suite of behavioral, neural, and molecular alterations that unfold across adolescence and into adulthood. To address this, we performed a longitudinal multimodal characterization of previously generated giant AnkB-440 KO monkeys, tracking them from adolescence through young adulthood (Fig. S1). Our analyses revealed heightened activity levels without stereotypical behaviors, multiple cognitive deficits including impairments in working memory, cognitive flexibility, and operant lever-press learning, as well as persistent structural and functional brain abnormalities. Notably, these mutant animals exhibited pronounced social interaction deficits, emotional dysregulation, and abnormalities in both metabolomic and blood transcriptomic profiles.
Collectively, these findings substantiate the involvement of giant ANK2 in critical neurofunctional domains and lay a potential platform for unraveling the cross-species mechanisms of giant ANK2-related neurological disorders, as well as developing possible therapeutic interventions in primates.
During a 7-year follow-up study, we performed a battery of behavioral tests to assess general symptoms, including neurological function, sleep patterns, exploratory behaviors, and manual dexterity, on the KO monkeys and age-matched wild-type (WT) monkeys (Fig. S1). Partly consistent with our previous observations for these monkeys from infancy to 2 years old [11], we found no significant differences between the 2 monkey groups at adolescent and young adulthood in these paradigms (Fig. S2A to E).
We adopted an artificial-intelligence-based 3-dimensional (3D) motion recognition framework [34,35] to estimate changes in free-moving behaviors and posture, which might decode the monkey’s behavioral sequence with higher granularity in both temporal (1/30 s, 30 fps) and spatial (millimeter-scale) levels (Fig. 1A). Under this framework, videos captured from a precalibrated multiview sampling system were conducted to automatically label and track 3D coordinates of 21 key body parts by a well-trained deep learning model for rhesus monkeys (Fig. 1A) [35]. The model precisely recognized the body parts and reconstructed the 3D skeletons matching the original postures, which ensured the reliability of the system and data for downstream analysis (Fig. 1A) and was used only for rhesus monkeys in this study.
In the subsequent investigation, we observed that the 2 KO rhesus monkeys could be clearly separated from 5 WT rhesus monkeys in the 2D space in the scores plot of principal components analysis (PCA) on the basis of extracted kinematic parameters (Fig. 1B). Group-by-group comparison illustrated that 43 of 46 parameters were significantly increased in the KO rhesus monkeys, including the moving speed and moving intensity of most of labeled body parts, as well as the moving distance per frame and body height (Fig. 1C and D and Table S1; e.g., moving speed of right knee, corrected P = 0.068; moving speed and intensity of other parts, corrected P < 0.05; distance, corrected P = 0.014; height, corrected P = 0.027). However, KO rhesus monkeys exhibited similar body length and body angle to those of the WT monkeys (Fig. 1D). We calculated the fold change of the KO rhesus monkeys as the ratio of KO to WT. Nearly half of the kinematic parameters that differed significantly were 2-fold higher in KO monkeys than in WT monkeys (e.g., movement speeds of head and shoulder regions), while the remaining parameters were approximately 1.5-fold higher (Fig. 1E). These data indicated that the KO rhesus monkeys exhibited stronger motional amplitude.
According to the position information in 3D coordinates, the location preference was determined. The location graph mapping the time proportion spent in any location by the monkeys demonstrated that the KO rhesus monkeys had no obvious position preference. In contrast, the WT rhesus monkey spent more time on a specific point, although each individual was heterogeneous, shown as the location heatmap (Fig. 1F). We analyzed 14 locomotor behaviors and categorized them into apparent displacement (AD) behaviors and non-AD (NAD) behaviors. The AD behaviors included climbing, falling, turning left/right, walking, and jumping, while the NAD behaviors included crouching, standing up, sitting, looking left/right, head rising/lowering, and hanging (Table S2). The KO rhesus monkeys displayed higher proportions in AD behaviors and lower proportions in NAD behaviors (Fig. 1G, AD: P = 0.054 and NAD: P = 0.014). Specifically, a higher movement fraction on turning left (P = 0.036) and turning right (P = 0.051) and a lower movement fraction on sitting (P = 0.020) and looking left (P = 0.036) were detected in KO rhesus monkeys (Fig. 1H). However, it exhibited significantly more head rising than the WT monkeys (Fig. 1H, P = 0.002). This behavior characteristic paralleled with the location pattern. We did not find significantly higher stereotypical behaviors in KO monkeys, resembling the infantile observations [11].
Collectively, these results indicated that KO rhesus monkeys exhibited increased activity, altered body postures, and a broad spectrum of general behavioral changes in the same novel environment.
As species-specific analysis showed no differences between rhesus and cynomolgus monkeys in performance on the cognitive tasks (Fig. S3), we combined data from both species to maximize the sample size within each experimental group. In the spatial delayed response (SDR) task (Fig. 2A), 4 KO monkeys (from both species) exhibited impaired working memory. In detail, they failed to reach the criterion of 86.7% correct responses when the delay B value exceeded 0 s. The KO monkeys presented a significantly lower percentage of correct responses at B = 2 s (Fig. 2B, P = 0.006) and also showed a significantly lower maximum B value than the 9 WT monkeys (Fig. 2C, P = 0.023). We also compared the average accuracy across all trials with B > 0 s using linear mixed-effects model (LMM). The significant fixed effect of delay (P < 0.001) revealed that accuracy decreased as the delay increased in both groups (Fig. 2D). In addition, a fixed effect of group was observed, indicating that the KO group performed worse than the WT group across all 5 delays: delay A (0 s, P = 0.070), delay B (P = 0.003), delay C (P < 0.001), delay D (P < 0.001), and delay E (P < 0.001) (Fig. 2D).
In the visual discrimination and reversal learning (VD/RL) task (Fig. 2E), the 4 KO monkeys presented normal association learning but insufficient cognitive flexibility. LMM revealed no differences in task stage × genotype interactions for trials to criteria (Fig. 2F) and errors to criterion (Fig. 2G), indicating that the pattern of task-related changes in trials or errors to criterion was comparable across groups. There were significant fixed effects of task stage (trials: P = 0.027 and errors: P < 0.001) and genotype (trials: P = 0.040 and errors: P = 0.023) on trials and errors before achieving criteria (Fig. 2F and G). Although post hoc comparisons by Fisher’s least significant difference (LSD) test showed no differences in the number of trials or errors during the VD stage, the KO group performed markedly more trials (Fig. 2F, P = 0.009) and errors (Fig. 2G, P = 0.003) to criteria than the WT monkeys when the stimulus-reward association was reversed in the RL stage. Likewise, KO monkeys had similar mean error rate relative to WT monkeys in the VD stage, whereas the mean error rate of KO monkeys was significantly higher than that of the WT monkeys in the RL stage (Fig. 2H, P = 0.026). A trial-by-trial analysis demonstrated that KO monkeys made 2 times more perseverative errors to achieve the criteria after reversal (Fig. 2I, P < 0.001). In addition, the 4 KO monkeys showed significantly lower performance on the operant learning (OL) task compared to eleven WT monkeys, as reflected by the need for more experimenter-guided/mannual training trials to reach criterion in KO monkeys (Fig. 2J, P = 0.044). This result suggested that the KO monkeys had impaired ability for OL. Taken together, KO of giant ANK2 in both species (rhesus and cynomolgus) might contribute the underlying cause of cognitive deficits in adolescent monkeys.
To test whether the giant ANK2 KO would impact the emotion and social interaction of monkeys, we performed emotional response (ER) tests and social interaction tests (SITs) on the monkeys. The mean retrieval latency across 5 sessions showed that the WT group displayed a significantly increased latency when neutral objects were shifted to the fear-inducing rubber cobra (P = 0.001), whereas no significant difference was found in the KO group, albeit there was a tendency for increased latency (P = 0.125) (Fig. 3A). Consistently, the approach-defense index calculated from behavioral scores also showed a significantly increased defensive behavior of WT monkeys (P = 0.001) but not of KO monkeys (P = 0.125) (Fig. 3B). These findings indicated that the KO group exhibited altered emotional responses to fearful stimuli and failed to inhibit their food retrieval responses. Note that the KO group had a small number of animals and the values should be interpreted with caution.
We next assessed the latency across the 5 sessions. A group-by-group comparison exhibited that the KO and WT groups had similar food-retrieval latencies in each session regardless of whether it was a neutral or negative condition (Fig. 3C). However, a within-group analysis revealed that the WT monkeys would adapt to the fearful objects, evidenced by a significant reduction of food-retrieval latency in the presence of the 3 stimuli as the testing sessions progressed (Fig. 3C, neutral: P < 0.001, spider: P = 0.011, and snake: P = 0.002). On the other hand, KO monkeys did not exhibit such an adaptation (Fig. 3C). Moreover, the 2 groups showed no difference in latency of neutral trials immediately before and after the snake emerged (Fig. S2E), indicating that the designed order in which negative stimuli were presented was not a factor affecting the results.
The observation from playback of behavioral records under the group-rearing condition showed that the KO monkeys presented a solitary trait (Fig. S2F) and the monkey T105 preferred to stay in the inner room rather than the outside room in the single colony unit (Fig. S2G). Quantitative analysis of the social behaviors showed that the 3 KO monkeys (from 2 species, excluding T105) were scored with a tendency toward lower social hierarchy (Fig. 3D) and lower social interaction time (Fig. 3E and F, P = 0.052). Moreover, they also exhibited significantly lower proactive grooming time (P = 0.018) and proactive grooming count (Fig. 3E and F, P = 0.018). However, no differences were found in the duration of passive grooming, passive social behaviors, and social withdrawal (Fig. S2H). Consequently, the social interaction deficit appeared specific to proactive behaviors. To further confirm this observation, we performed the 3-chamber SIT in rhesus monkeys (Fig. 3G). In the social affiliation test (phase 1), the 2 KO rhesus monkeys spent significantly more time approaching the nonsocial object (toy monkey) than stranger 1 (P < 0.001), and this nonsocial approaching duration was also significantly prolonged compared with that of WT monkeys (Fig. 3H and I, P = 0.001). In the social memory test (phase 2), KO monkeys displayed increased social avoidance, spending significantly longer time distant from both strangers 1 and 2, relative to WT monkeys (Fig. 3H and J, P = 0.021). No significant difference was observed between approach and avoidance durations toward the 2 conspecifics in KO monkeys, whereas WT monkeys exhibited significantly longer approach than avoidance durations toward both strangers (Fig. 3J, P < 0.001). Together, the results suggested that KO monkeys prefer nonsocial objects over conspecifics, which may explain their diminished proactive behaviors in the group.
Consistent with our previous observation of drastic brain structural change in these KO monkeys at 6, 12, and 24 months of age [11], we found sustained cerebral ventricular enlargement in KO monkeys by 4 years of age, leading to pronounced morphological alterations in the occipital, temporal, and posterior parietal lobes (Fig. 4A). To minimize segmentation errors resulting from these anatomical alterations, we restricted the structural and functional MRI analysis to the frontal lobe (29 regions), the anterior parietal lobe (10 regions), and 6 subcortical regions (Table S3 and Fig. S4).
We first examined cortical gray matter thickness (GMT). KO monkeys of both species showed significantly reduced GMT in 3 frontal regions (area 24a/b: corrected P < 0.001, area 24a/b prime: corrected P = 0.007, and area 25: corrected P = 0.033) compared to WT monkeys. At the uncorrected threshold, area 32 also showed reduced GMT (P = 0.019) in KO monkeys (Fig. 4B). In contrast, area 24c showed significantly increased GMT in KO monkeys relative to WT monkeys (corrected P = 0.007) (Fig. 4B). No significant differences were observed in parietal regions, either before or after correction. Overall, these GMT analyses demonstrated altered frontal cortical gray matter in KO monkeys, with most false discovery rate (FDR)-corrected regions showing reduced thickness (Fig. 4B and C). To further characterize the changes in gray matter morphology, we analyzed cortical surface area and gray matter volume. These analyses identified several regions showing group differences at the uncorrected threshold, with most regions showing reduced values in KO monkeys (Fig. S5A to D). Among the subcortical regions examined, pallidum volume was significantly reduced in KO monkeys (Fig. 4D, corrected P = 0.030). We also examined T1-weighted/T2-weighted-based myelination estimates. KO monkeys exhibited significantly increased myelination in 2 subcortical structures (Fig. 4E, hypothalamus: corrected P = 0.004 and pallidum: corrected P = 0.019). Additional increases were observed at the uncorrected threshold in the accumbens (P = 0.036), putamen (P = 0.008), M1 (P = 0.036), and medial agranular insular area (lam)/posteromedial agranular insular area (lapm) (P = 0.040), although these did not reach FDR-corrected significance.
Next, we analyzed functional connectivity (FC) based on resting-state functional MRI (rs-fMRI) data using generalized LMMs at both the lobar and regional levels. At the lobar level, KO monkeys exhibited altered intra- and interhemispheric FC patterns (Fig. 4F). Specifically, intrahemispheric FC within the parietal lobe was significantly increased (corrected P = 0.025), while intrahemispheric FC between subcortical structures and the frontal lobe was significantly decreased (corrected P = 0.032) (Fig. 4F). At the uncorrected threshold, interhemispheric FC within the parietal lobe was increased (P = 0.025), whereas interhemispheric FC among subcortical structures (P = 0.026) and interhemispheric FC between subcortical structures and the frontal lobe (P = 0.026) were reduced (Fig. 4F). At the regional level, 2 parietal regions in KO monkeys, including area 7op (corrected P = 0.011) and area 5d (corrected P = 0.011), showed significantly increased FC density (FCD) (Fig. 4G and H). Additional differences were observed at the uncorrected threshold, including increased FCD in superior parietal lobule area (PEa) (P = 0.007) and reduced FCD in 3 frontal regions—area 24a/b (P = 0.010), area 14 (P = 0.036), and area 10 (P = 0.046)—as well as in the accumbens (Acb; P = 0.008) and putamen (Pu; P = 0.017) (Fig. 4G and H).
Beyond FC, we further characterized differences in brain network topology between WT and KO monkeys. The KO monkeys presented a significant reduction in the global small-world parameter σ (Fig. 4I, corrected P = 0.007), reflecting altered balance between local clustering and long-range connectivity within the analyzed network. Degree centrality (Dc) analyses revealed significant increases in 3 parietal regions, including PEa, area 5d, and area 7op, as well as in one frontal region, area 8A, whereas the putamen showed a significant decrease in Dc (all corrected P < 0.05; Fig. S6A to C). Additional Dc changes were observed at the uncorrected threshold in frontal regions, parietal regions, and subcortical structures, including increased Dc in presupplementary motor area (preSMA), dorsal premotor cortex, and areas 1-2, and reduced Dc in area 24a/b, area 3a/b, area 10, area 9, area 46d, area 13, area 24c, and accumbens (Fig. S6A to C). Furthermore, nodal clustering coefficient (NCp) also showed significant group differences (corrected P < 0.05) in multiple regions (Fig. S6D to F). Specifically, NCp was significantly increased in several frontal and parietal regions, including SMA, area 3a/b, area 24c prime, and preSMA, whereas area 25 and area 24a/b showed significantly reduced NCp. Additional NCp differences at the uncorrected threshold were observed in frontal, parietal, and subcortical regions, including increased NCp in secondary somatosensory cortex, ventral premotor cortex, hypothalamus, areas 1 and 2, M1, lateral intraparietal area, and area 8B (Fig. S6D). Detailed regional results are provided in Tables S4 to S6.
To assess the behavioral relevance of the regional neuroimaging abnormalities, we performed exploratory brain–behavior correlation analyses using 3 representative behavioral measures and neuroimaging measures that showed significant group differences after FDR correction. Partial Spearman correlations controlling for species and genotype showed that working memory accuracy at B = 2 s was positively associated with cortical thickness in area 24a/b prime (P = 0.015) and with Dc of the putamen (P < 0.001; Fig. S7). No significant associations were found between neuroimaging measures and RL perseverative errors or cobra-minus-neutral retrieval latency. Together, these results indicate that regionally selective cortical structural and subcortical network abnormalities may be associated with the working memory impairment observed in giant ANK2 KO monkeys.
There were no significant differences in physical development (Fig. S8) and echocardiogram indices between the giant ANK2 KO and WT monkeys, consistent with our previous report [11], except for a lower aortic valve velocity in KO monkeys (Table S7). These observations suggested that KO of giant ANK2 may not cause problems with the heart and other organs although previous studies have shown an association of ANK2 mutations with cardiovascular diseases and other diseases [15–17,36].
In the blood biochemistry test, we found significantly lower levels of total bilirubin (P = 0.037), total protein (P = 0.037), globulin (P = 0.007), blood urea nitrogen (P = 0.007), total protein-to-albumin ratio (P = 0.003), higher alanine aminotransferase (P = 0.022), and albumin-to-globulin ratio (P = 0.003) in the KO group (n = 4) compared to the age-matched WT group with large sample size (n = 78) (Fig. 5A). Moreover, the KO monkey exhibited a significantly lower mean corpuscular volume (P = 0.002) and a marginal significance of a higher red blood cell count (P = 0.080) when compared to the WT group (n = 11) across 3 measures during the development (Fig. 5B). Other hematological parameters with no significant difference were shown in Table S8. The development-related hormone, i.e., cortisol and testosterone, had no significant differences between the 2 groups (Fig. 5C). However, we found that monkey T105 had abnormally elevated testosterone (5.35 ng/ml) and a high testosterone-to-cortisol ratio (9.12) (Fig. 5C), both exceeded the normal range observed in age- and species-matched WT males (testosterone-to-cortisol ratio =1.22 ± 0.20, n = 8, means ± SEM). At age 3, it was also larger (body length, 53 cm) and heavier (body weight, 6.08 kg) than male control monkeys (length, 44 ± 0.44 cm; weight, 3.7 ± 0.04 kg; n = 3, means ± SEM). We assumed that these changes may be associated with the abnormal behavior of this monkey (Fig. S2G).
The lipid metabolism was closely related to brain development, aging, and disorders [37,38]. We therefore performed a targeted lipidomic profiling of cerebrospinal fluid (CSF) and serum using liquid chromatography–mass spectrometry (Fig. S9A). At the uncorrected threshold, whereas few lipid molecules in serum were altered in KO versus WT groups, CSF showed extensive changes (fold change > 1.5 or < 0.67, P < 0.05), prompting our subsequent focus on CSF (Fig. 5D and Table S9). Notably, almost all differential lipids were up-regulated. While a phosphatidylinositol (PI) species showed the highest fold change (Fig. 5D), the vast majority fell under that of glycerolipids where triglyceride (TG) species predominated, and the second most highly changed category were glycerophospholipid (GP) that was mainly composed of phosphatidylethanolamine (PE) (Fig. 5E). Consistently, overall TG concentration was higher in KO monkeys (P = 0.004, Fig. 5F) than in WT monkeys, while total glycerolipids and all other lipid categories did not change (Fig. S9B). Note that up-regulation affected a sizable fraction of both TG and PE species (Fig. 5G).
We next examined lipid structural changes, i.e., chain length as carbon number and saturation as double-bond count, where a higher double-bond indicated greater unsaturation. At the uncorrected threshold, KO monkeys showed elevated TG concentrations across most chain lengths, with increases in mid-length species (Fig. 5H, all P < 0.05). Moreover, GP species including PE, PI, and alkyl-PE (PE-O) at specific chain lengths were also increased in KO monkeys (Fig. 5I, all P < 0.05). Unsaturated TG concentrations were preferentially elevated in moderately unsaturated species, raising the total concentration of unsaturated TG and the unsaturated TG fraction in KO monkeys (Fig. 5J and Fig. S9C, all P < 0.05). The membrane fluidity was assessed on the basis of GP-associated indicators, i.e., saturated fractions and unsaturated concentrations of GP, phosphatidylcholine (PC), and PE class (including PE, PE-O, and alkenyl-PE [PE-P]) following a previous study [38]. The saturated fractions were negatively correlated with fluidity, while unsaturated concentrations were positively correlated. However, no significant changes in fluidity were detected between the 2 groups (Fig. S9D). Despite this, specific PE/PE-O species with fewer double bonds and saturated PI were significantly increased in KO monkeys (Fig. 5K, all P < 0.05). Collectively, our CSF lipidomic analyses showed that giant ANK2 KO up-regulates TG and GP species in monkey CSF, potentially linking KO of giant ANK2 to the disruption of brain lipid homeostasis in monkeys.
To further investigate the physiological impact of giant ANK2 ablation, we compared peripheral blood transcriptomic profiles between KO and WT monkeys. Among genes with over 2-fold expressional changes in KO cynomolgus monkeys (1936 genes) and KO rhesus monkeys (524 genes) (|log2 fold change| >1 and P < 0.05), a number of genes related to immune processes were dysregulated at the uncorrected threshold. Gene expression and differential expression patterns (represented by log2 fold change) were strongly correlated between the 2 monkey species (Fig. S10). The observed differences in the number of differentially expressed genes (DEGs) between species might reflect underlying genomic variability [39] or differential compensatory responses to ANK2 depletion. Genes with important roles in inflammatory regulation, including TLR5, CCL2, AUZ, TARM1, and CLEC4D, were down-regulated in KO cynomolgus monkeys (Fig. 6A). Key molecules involved in the type I interferon signaling pathway, such as IFI6, IFIT3, OAS1, OASL, RSAD2, and MX1 were also remarkably down-regulated in KO rhesus monkeys (Fig. 6B). DEGs in these 2 groups of KO monkeys were enriched in immune-process-related pathways, especially for pathways related to cytokine production (GO:0001819, positive regulation of cytokine production; Fig. 6C). Among commonly dysregulated genes shared by both KO monkey species, a large proportion of genes were related to the immune process, including TLR5, CLEC1A, ATF3, GPR84, ENTPD1, ADGRE1, KLRC1, CXCR6, and NCR1 (Fig. 6D). These results were consistent with immune system abnormalities and cytokine alterations in patients with ASD reported by previous studies [40]. Furthermore, the mRNA expression levels of immune-related genes and the protein levels of cytokines and other immune-related proteins were significantly altered in the peripheral blood of patients with ASD [40,41]. Future validation experiments should be performed to determine whether these DEGs and enriched pathways participate in brain pathology caused by the giant ANK2 KO.
The ANK2 gene is highly conserved, with its protein AnkB expressed in organs, such as the brain, heart, skeletal muscle, and thymus [16], and its mutations associated with many diseases, especially NDDs, including ASD [17,36,42]. In our previous study, we generated rhesus and cynomolgus monkeys deficient of the giant ANK2 isoform AnkB-440 [11]. These KO monkeys from both species exhibited massive brain volume loss at early ages (6 months, 1 year, and 2 years) [11] and sustained this loss up to 4 years of age or older. We proposed that this structural defect would cause neural impairments that emerge with development and aging, rather than in infancy [11]. In this study, longitudinal studies of the giant ANK2 KO monkeys revealed hyperactivity, cognitive deficits (in working memory, flexibility, and OL), and disrupted social interactions, aligning with human ANK2 mutation phenotypes [43]. However, the hyperactivity contrasted with the mice carrying an analogous AnkB-440 mutation, which showed reduced activity [10], suggesting species-specific differences. In addition, the giant ANK2 KO monkeys displayed emotional dysregulation, and adolescent KO monkeys exhibited social deficits and a disrupted social hierarchy or affiliation in the colony, probably due to increased avoidance rather than approaching behavior, aligning with prenatally valproate-induced ASD-like rats and schizophrenia [44,45]. Although these KO monkeys displayed social deficits, they did not exhibit overt stereotypical behaviors; thus, we cannot conclude that they fully recapitulate ASD. Nevertheless, they may model specific symptomatic features of NDDs. Of note, these behavioral abnormalities were not present during infancy or juvenility [11] but emerged in KO monkeys as social hierarchy structures matured. Consequently, detecting social behavioral differences in infant monkeys is inherently challenging.
Giant ANK2 KO monkeys showed persistent cerebral ventricular enlargement, resulting in morphological alterations in the occipital, temporal, and posterior parietal lobes, as well as some subcortical regions. Outside these regions of structural change, they exhibited reduced GMT in several frontal cortical regions, particularly within cingulate areas, which may be associated with impairments in working memory and cognitive flexibility found in this study. Notably, difficulty in learning an operant task mirrored intellectual disabilities observed in ANK2 mutation patients [43]. Moreover, rs-fMRI revealed significantly increased FCD in parietal areas, with additional reductions in frontal and subcortical regions observed at the uncorrected threshold, indicating altered regional importance within the analyzed network. Network integration and segregation were also disrupted, characterized by a significantly reduced small-world coefficient and significant region-specific changes in NCp, with additional NCp differences observed at the uncorrected threshold, which may contribute to the observed behavioral abnormalities [46,47]. Importantly, the regional neuroimaging abnormalities showed behavioral relevance: Poorer working memory performance was associated with reduced cortical thickness in area 24a/b prime and lower Dc of the putamen. These findings provide evidence linking regionally selective brain abnormalities to the cognitive phenotype of giant ANK2 depletion, although the exploratory nature and small sample size of the correlation analyses warrant validation in larger cohorts.
Intriguingly, in mice, homozygous deletion of ANK2 restricted to cortical and hippocampal excitatory neurons results in ASD-like behaviors and leads to juvenile seizure-related mortality [48]. In human patients, ANK2 mutations have been associated with epilepsy [43,49]. Moreover, the ANK2 variants have been linked to an inherited disorder known as “AnkB syndrome”, characterized by a range of cardiac arrhythmias and cardiomyopathy [15,16]. We observed no epilepsy or cardiac dysfunction in the giant ANK2 KO monkeys during the continual investigation up to 7 years of age and no elevated neuronal synchronies as seen in epileptic mice [8]. However, the disrupted small-world coefficient in KO monkeys aligned with the findings in childhood absence epilepsy syndrome [50]. Long-term monitoring of cardiac function in these KO monkeys is warranted, particularly at key developmental stages such as middle and old ages. In addition, the KO monkeys with cerebral ventricular enlargement, a feature previously reported in patients with schizophrenia [51], exhibited significantly higher movement speed. This was compatible with the positive symptoms observed in schizophrenia [52]. Future studies could investigate whether these monkeys also display impaired sensory gating and auditory deficits, a well-established clinical hallmark of the psychiatric disorder, to confirm whether these KO monkeys had schizophrenia-like symptoms.
Consistent with our previous study [11], most physical indices showed no significant differences between KO and WT monkeys. Although there were no significant intergroup differences in body weight across development, 2 outlier individuals deserve attention. One male KO rhesus monkey (T105) exhibited social isolation, necessitating separate housing for its welfare. It showed abnormally elevated testosterone, which is related to aggression and may contribute to ASD [53], and a larger body size relative to age- and species-matched WT monkeys. This particular case of excessive development might represent an alternate NDD manifestation, suggesting a link between abnormal hormone profiles and alterations in behavior and physical growth [54]. However, it remains unclear whether the behavioral alterations in this monkey are associated with such hormonal abnormalities or the gene deletion. Probably, these 2 factors may interact with each other, and further experiments are required to verify their causal relationship. On the contrary, one dwarf female cynomolgus KO monkey (T88) exhibited consistently low body weight (below 2.75 kg) from infancy through adulthood and reduced blood glucose levels (fasting, 2.4 mmol/l; 1 h after feeding, 2.6 mmol/l). Given that the absence of CRISPR/Cas9 off-target effects has been confirmed in our previous study [11], this observation suggested that giant ANK2 KO may cause complex, variable physiological outcomes, potentially influenced by KO efficiency, gender-dependent response to gene editing, and species-specific factors, although a small fraction of genes (3.7%) showed differential expression between the 2 species [39].
Compared with age-matched WT monkeys, the giant ANK2 KO monkeys exhibited several alternations in hematological and biochemical parameters, suggesting that the giant ANK2 KO may exert broad effects on monkey’s physiological processes. Furthermore, our data showed that ANK2 KO monkeys have elevated CSF levels of TG and GP compared to controls, while blood lipid levels remain unchanged. These KO animals also exhibited cognitive deficits. Although regional neuroimaging abnormalities correlated with behavioral changes, the co-occurrence of CSF lipid alterations and cognitive impairment was well documented. This association was supported by previous findings in both humans and rodents [55,56] and was corroborated by clinical evidence identifying TG as strongly associated with cognitive decline in Alzheimer’s disease [57] and in aging individuals with cognitive dysfunction [58]. Furthermore, the concurrent increase in diacylglycerols and PI (15:0/17:0) may point to aberrant PI signaling in the brain following giant ANK2 deletion, a pathway recently implicated in neurodevelopment [59]. However, the current data are limited at the uncorrected threshold due to the small sample size and do not establish a causal link nor elucidate the underlying mechanisms. Whether and how these lipid changes contribute to the cognitive deficits remain open questions that necessitate further investigation. For example, it would be valuable to determine whether the elevated TG/phosphatidylglycerol species are localized to specific cognition-related brain regions and to explore their potential connections to excitatory/inhibitory transmission via pyramidal cells and interneurons, once brain tissues or organoids become available.
Peripheral blood transcriptome analysis suggested dysregulated immune-related genes (e.g., TLR5, CCL2, AUZ, TARM1, and CLEC4D) and associated pathways in giant ANK2 KO monkeys. Whether and how these molecules contribute to the pathological mechanisms underlying NDD- or ASD-like behaviors associated with ANK2 mutations await further studies using in vivo targeted gene editing or pharmacological manipulation. One interesting question arising from these data is why more DEGs were observed in cynomolgus monkeys compared to rhesus monkeys following giant ANK2 KO. Focused study with large cohorts of KO animals would help clarify this species-specific difference.
This study has several limitations. First, the small cohort of giant ANK2-deficient monkeys necessitates validation with a larger sample. We are currently expanding the breeding of these animals to reduce variability and obtain more robust insights into the functional alterations resulting from giant ANK2 KO. Second, our MRI and rs-fMRI analyses were necessarily confined to anatomically reliable frontal, anterior parietal, and selected subcortical regions. The observed structural, FC, and graph theoretical alterations characterize abnormalities within this retained frontoparietal–subcortical network, while their generalizability to the excluded regions and whole-brain network organization remains to be established. The lack of brain tissues at different developmental stages prevented molecular/cellular analyses from examining neuronal changes. The expanded cohort and establishment of brain organoids combining with emerging technologies on single-cell sequencing, such as artificial-intelligence-based spatial cellular profiling and single-cell-specific causal network [60,61], may provide more insights into dynamical processes of brain loss and its underlying mechanism. Third, although lipidomic and transcriptomic analyses suggested alterations in metabolic and immune pathways associated with ANK2 depletion, these data remain to be further validated, and further functional validations are necessary to elucidate the molecular mechanisms underlying these observed changes.
In summary, we conducted a longitudinal study of monkeys deficient in giant ANK2, establishing a comprehensive lifespan timeline of behavioral, neuroimaging, and physiological changes in these KO monkeys. Extending our earlier observations from infancy [11], these KO monkeys developed progressive behavioral abnormalities with age, including cognitive, emotional, and social deficits. They also exhibited alternations in brain structure and function, alongside dysregulated lipidomic and immune-related transcriptomic profiles. These findings suggest that giant ANK2 depletion in NHPs recapitulates key phenotypic features of human NDDs, offering cross-species insights into brain functional development and distinct dimensions of disease pathogenesis, and can thereby aid future mechanistic and therapeutic research.
For details about the materials and methods, please see the Supplementary Materials.
1.
Thapar A, Cooper M, Rutter M.Neurodevelopmental disorders. Lancet Psychiatry. 2017;4(4):339–346.
2.
Shapiro BK, Ismail FY.What are neurodevelopmental disorders? Curr Opin Neurol. 2019;32(4):611–616.
3.
Morris-Rosendahl DJ, Crocq MA.Neurodevelopmental disorders-the history and future of a diagnostic concept. Dialogues Clin Neurosci. 2020;22(1):65–72.
4.
Li Z, Zhu YX, Gu LJ, Cheng Y.Understanding autism spectrum disorders with animal models: Applications, insights, and perspectives. Zool Res. 2021;42(6):800–824.
5.
Sun J, Noss S, Banerjee D, Das M, Girirajan S.Strategies for dissecting the complexity of neurodevelopmental disorders. Trends Genet. 2024;40(2):187–202.
6.
Parikshak NN, Gandal MJ, Geschwind DH.Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet. 2015;16(8):441–458.
7.
Kawano S, Baba M, Fukushima H, Miura D, Hashimoto H, Nakazawa T.Autism-associated ANK2 regulates embryonic neurodevelopment. Biochem Biophys Res Commun. 2022;605:45–50.
8.
Yoon S, Santos MD, Forrest MP, Pratt CP, Khalatyan N, Mohler PJ, Savas JN, Penzes P.Early developmental deletion of forebrain Ank2 causes seizure-related phenotypes by reshaping the synaptic proteome. Cell Rep. 2023;42(7):Article 112784.
9.
Creighton BA, Afriyie S, Ajit D, Casingal CR, Voos KM, Reger J, Burch AM, Dyne E, Bay J, Huang JK, et al.Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A. Elife. 2021;10:Article e69815.
10.
Yang R, Walder-Christensen KK, Kim N, Wu D, Lorenzo DN, Badea A, Jiang YH, Yin HH, Wetsel WC, Bennett V.ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity. Proc Natl Acad Sci USA. 2019;116(30):15262–15271.
11.
Qin DD, Zhou JK, He XC, Shen XY, Li C, Chen HZ, Yan LZ, Hu ZF, Li X, Lv LB, et al.Depletion of giant ANK2 in monkeys causes drastic brain volume loss. Cell Discov. 2021;7(1):113.
12.
Murphy KE, Duncan B, Sperringer JE, Zhang E, Haberman V, Wyatt EV, Maness P.Ankyrin B promotes developmental spine regulation in the mouse prefrontal cortex. Cereb Cortex. 2023;33(20):10634–10648.
13.
Guan H, Maness PF.Perisomatic GABAergic innervation in prefrontal cortex is regulated by ankyrin interaction with the L1 cell adhesion molecule. Cereb Cortex. 2010;20(11):2684–2693.
14.
Galiano MR, Jha S, Ho TS, Zhang C, Ogawa Y, Chang KJ, Stankewich MC, Mohler PJ, Rasband MN.A distal axonal cytoskeleton forms an intra-axonal boundary that controls axon initial segment assembly. Cell. 2012;149(5):1125–1139.
15.
Mohler PJ, Le Scouarnec S, Denjoy I, Lowe JS, Guicheney P, Caron L, Driskell IM, Schott JJ, Norris K, Leenhardt A, et al.Defining the cellular phenotype of “Ankyrin-B syndrome” variants: Human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation. 2007;115(4):432–441.
16.
York NS, Sanchez-Arias JC, McAdam ACH, Rivera JE, Arbour LT, Swayne LA.Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease. Front Cardiovasc Med. 2022;9:Article 964675.
17.
Yoon S, Penzes P.Roles of ANK2/ankyrin-B in neurodevelopmental disorders: Isoform functions and implications for autism spectrum disorder and epilepsy. Curr Opin Neurobiol. 2025;90:Article 102938.
18.
Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, et al.Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020;180(3):568–584.e523.
19.
Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, Murtha MT, Bal VH, Bishop SL, Dong S, et al.Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron. 2015;87(6):1215–1233.
20.
De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, et al.Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209–215.
21.
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee YH, Narzisi G, Leotta A, et al.De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74(2):285–299.
22.
Wang T, Hoekzema K, Vecchio D, Wu H, Sulovari A, Coe BP, Gillentine MA, Wilfert AB, Perez-Jurado LA, Kvarnung M, et al.Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. Nat Commun. 2020;11(1):4932.
23.
Coe BP, Stessman HAF, Sulovari A, Geisheker MR, Bakken TE, Lake AM, Dougherty JD, Lein ES, Hormozdiari F, Bernier RA, et al.Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nat Genet. 2019;51(1):106–116.
24.
Bowling KM, Thompson ML, Amaral MD, Finnila CR, Hiatt SM, Engel KL, Cochran JN, Brothers KB, East KM, Gray DE, et al.Genomic diagnosis for children with intellectual disability and/or developmental delay. Genome Med. 2017;9(1):43.
25.
Lorenzo DN, Badea A, Davis J, Hostettler J, He J, Zhong G, Zhuang X, Bennett V.A PIK3C3-Ankyrin-B-dynactin pathway promotes axonal growth and multiorganelle transport. J Cell Biol. 2014;207(6):735–752.
26.
Scotland P, Zhou D, Benveniste H, Bennett V.Nervous system defects of AnkyrinB (−/−) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol. 1998;143(5):1305–1315.
27.
Feng G, Jensen FE, Greely HT, Okano H, Treue S, Roberts AC, Fox JG, Caddick S, Poo MM, Newsome WT, et al.Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research. Proc Natl Acad Sci USA. 2020;117(39):24022–24031.
28.
Zhao H, Tu Z, Xu H, Yan S, Yan H, Zheng Y, Yang W, Zheng J, Li Z, Tian R, et al.Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate. Cell Res. 2017;27(10):1293–1297.
29.
Yang W, Guo X, Tu Z, Chen X, Han R, Liu Y, Yan S, Wang Q, Wang Z, Zhao X, et al.PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis. Protein Cell. 2022;13(1):26–46.
30.
Scott JT, Bourne JA.Modelling behaviors relevant to brain disorders in the nonhuman primate: Are we there yet? Prog Neurobiol. 2022;208:Article 102183.
31.
Phillips KA, Bales KL, Capitanio JP, Conley A, Czoty PW, Hart BA, Hopkins WD, Hu SL, Miller LA, Nader MA, et al.Why primate models matter. Am J Primatol. 2014;76(9):801–827.
32.
Yao YG, Construction Team of the KIZ Primate Facility.Towards the peak: The 10-year journey of the National Research Facility for phenotypic and genetic analysis of model animals (primate facility) and a call for international collaboration in non-human primate research. Zool Res. 2022;43(2):237–240.
33.
Zhang L, Wang JH.The utilization of non-human primates in the investigation of autism spectrum disorder. Brain Res. 2025;1866:Article 149900.
34.
Hao Y, Yu B, Qin M, Qin T, Wang J, Wei Y, Zhao C, Xing Y, Yuan Y, Xue T, et al.Extracellular vesicles from antler blastema progenitor cells reverse bone loss and mitigate aging-related phenotypes in mice and macaques. Nat Aging. 2025;5(9):1790–1809.
35.
Zhang YL, Qiao YC, Ji YC, Huang HD, Zhang L, Ruan JX, Li CY, Xie HH, Zhang BL, Zhou Q, et al.A study of spontaneous self-injurious behavior and neuroimaging in rhesus macaques. Research. 2025;8:0782.
36.
Voos KM, Tzeng J, Patel P, Rubinsky S, Choi HE, Pharr T, Sookram S, Baur JA, Soderblom EJ, Lorenzo DN.Ankyrin-B modulates mitochondrial fission in skeletal muscle and is required for optimal endurance exercise capacity. Nat Commun. 2025;16(1):7671.
37.
Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A, Shin YS, Moon MH, An HJ, Wenk MR, et al.Brain lipidomics: From functional landscape to clinical significance. Sci Adv. 2022;8(37):eadc9317.
38.
Yu Q, He Z, Zubkov D, Huang S, Kurochkin I, Yang X, Halene T, Willmitzer L, Giavalisco P, Akbarian S, et al.Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders. Mol Psychiatry. 2020;25(11):2952–2969.
39.
Mao YX, Li Y, Yang Z, Xu N, Zhang S, Wang X, Yang X, Sun Q, Mao Y.Comparative transcriptome analysis between rhesus macaques (Macaca mulatta) and crab-eating macaques (M. fascicularis). Zool Res. 2024;45(2):299–310.
40.
Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ.Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis. Mol Psychiatry. 2015;20(4):440–446.
41.
Saffari A, Arno M, Nasser E, Ronald A, Wong CCY, Schalkwyk LC, Mill J, Dudbridge F, Meaburn EL.RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation. Mol Autism. 2019;10(1):38.
42.
Zhu W, Wang C, Hu J, Wan R, Yu J, Xie J, Ma J, Guo L, Ge J, Qiu Y, et al.Ankyrin-B Q1283H variant linked to arrhythmias via loss of local protein phosphatase 2A activity causes ryanodine receptor hyperphosphorylation. Circulation. 2018;138(23):2682–2697.
43.
Zhao L, Qiao ZD, Jia YX, Fu JX, Li TX, Jia KR, Zhao H, Bao JP, Yang XF, Pan H, et al.A mutation in the ANK2 gene causing ASD and a review of the literature. Mol Genet Genomic Med. 2025;13(3):Article e70083.
44.
Sutliff S, Roy MA, Achim AM.Social anxiety disorder in recent onset schizophrenia spectrum disorders: The relation with symptomatology, anxiety, and social rank. Psychiatry Res. 2015;227:39–45.
45.
Pelsőczi P, Kelemen K, Csölle C, Nagy G, Lendvai B, Román V, Lévay G.Disrupted social hierarchy in prenatally valproate-exposed autistic-like rats. Front Behav Neurosci. 2019;13:295.
46.
Zhao X, Liu Y, Wang X, Liu B, Xi Q, Guo Q, Jiang H, Jiang T, Wang P.Disrupted small-world brain networks in moderate Alzheimer’s disease: A resting-state FMRI study. PLOS ONE. 2012;7(3):Article e33540.
47.
Liao X, Vasilakos AV, He Y.Small-world human brain networks: Perspectives and challenges. Neurosci Biobehav Rev. 2017;77:286–300.
48.
Oh H, Lee S, Oh Y, Kim S, Kim YS, Yang Y, Choi W, Yoo Y-E, Cho H, Lee S, et al.Kv7/KCNQ potassium channels in cortical hyperexcitability and juvenile seizure-related death in Ank2-mutant mice. Nat Commun. 2023;14(1):3547.
49.
Teunissen MWA, Lewerissa E, van Hugte EJH, Wang S, Ockeloen CW, Koolen DA, Pfundt R, Marcelis CLM, Brilstra E, Howe JL, et al.ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks. Hum Mol Genet. 2023;32(14):2373–2385.
50.
Drenthen GS, Fasen F, Fonseca Wald ELA, Backes WH, Aldenkamp AP, Vermeulen RJ, Debeij-van Hall M, Hendriksen J, Klinkenberg S, Jansen JFA.Functional brain network characteristics are associated with epilepsy severity in childhood absence epilepsy. Neuroimage Clin. 2020;27:Article 102264.
51.
Gaser C, Nenadic I, Buchsbaum BR, Hazlett EA, Buchsbaum MS.Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am J Psychiatry. 2004;161(1):154–156.
52.
Andreasen NC, Olsen SA, Dennert JW, Smith MR.Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. Am J Psychiatry. 1982;139(3):297–302.
53.
Ostatníková D, Lakatošová S, Babková J, Hodosy J, Celec P.Testosterone and the brain: From cognition to autism. Physiol Res. 2020;69(Suppl 3):S403–S419.
54.
Chowen JA, Garcia-Segura LM, Gonzalez-Parra S, Argente J.Sex steroid effects on the development and functioning of the growth hormone axis. Cell Mol Neurobiol. 1996;16(3):297–310.
55.
Schuurs-Hoeijmakers JH, Geraghty MT, Kamsteeg EJ, Ben-Salem S, de Bot ST, Nijhof B, De Vondervoort Van II, Van Der Graaf M, Nobau AC, Otte-Höller I, et al.Mutations in DDHD2, encoding an intracellular phospholipase A1, cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet. 2012;91(6):1073–1081.
56.
Inloes JM, Hsu KL, Dix MM, Viader A, Masuda K, Takei T, Wood MR, Cravatt BF.The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase. Proc Natl Acad Sci USA. 2014;111(41):14924–14929.
57.
Dakterzada F, Jové M, Huerto R, Carnes A, Sol J, Pamplona R, Piñol-Ripoll G.Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease. Geroscience. 2024;46(1):683–696.
58.
Ralhan I, Chang CL, Lippincott-Schwartz J, Ioannou MS.Lipid droplets in the nervous system. J Cell Biol. 2021;220(7):Article e202102136.
59.
Tang I, Nisal A, Reed A, Ware TB, Johansen A, Zaki MS, Cravatt BF, Gleeson JG.Lipidomic profiling of mouse brain and human neuron cultures reveals a role for Mboat7 in mTOR-dependent neuronal migration. Sci Transl Med. 2025;17(779):eadp5247.
60.
Ge Y, Leng J, Tang Z, Wang K, U K, Zhang SM, Han S, Zhang Y, Xiang J, Yang S, et al.Deep learning-enabled integration of histology and transcriptomics for tissue spatial profile analysis. Research. 2025;8:0568.
61.
Huang X, Chen L, Liu X.Constructing cell-specific causal networks of individual cells for depicting dynamical biological processes. Research. 2025;8:0743.
62.
Wang JH, Rizak JD, Chen YM, Li L, Hu XT, Ma YY.Interactive effects of morphine and dopaminergic compounds on spatial working memory in rhesus monkeys. Neurosci Bull. 2013;29(1):37–46.
63.
Pujara MS, Rudebeck PH, Ciesinski NK, Murray EA.Heightened defensive responses following subtotal lesions of macaque orbitofrontal cortex. J Neurosci. 2019;39(21):4133–4141.
64.
Zhang Z, Dong X, Liu Z, Liu N.Social status predicts physiological and behavioral responses to chronic stress in rhesus monkeys. IScience. 2024;27(6):Article 110073.
65.
Dai P, Huang H, Zhang L, He J, Zhao X, Yang F, Zhao N, Yang J, Ge L, Lin Y, et al.A pilot study on transient ischemic stroke induced with endothelin-1 in the rhesus monkeys. Sci Rep. 2017;7(1):Article 45097.
66.
Yang L, Han B, Zhang Z, Wang S, Bai Y, Zhang Y, Tang Y, Du L, Xu L, Wu F, et al.Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models. Circulation. 2020;142(6):556–574.
67.
Zhang BL, Chen Y, Zhang Y, Qiao Y, Wu Y, Zhang Y, Lu Y, You X, Li Y, Huang HD, et al.Forward and reverse genomic screens enhance the understanding of phenotypic variation in a large Chinese rhesus macaque cohort. Nat Commun. 2025;16(1):8703.
68.
Huang K, Han Y, Chen K, Pan H, Zhao G, Yi W, Li X, Liu S, Wei P, Wang L.A hierarchical 3D-motion learning framework for animal spontaneous behavior mapping. Nat Commun. 2021;12(1):2784.
69.
Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN.Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004;3(5):287–302.
70.
Cox RW.AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29(3):162–173.
71.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, et al.Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(Suppl 1):S208–S219.
72.
Avants B, Tustison NJ, Song G.Advanced normalization tools: V1.0. Insight J. 2009;2(365):1–35.
73.
Fischl B.FreeSurfer. Neuroimage. 2012;62(2):774–781.
74.
Jung B, Taylor PA, Seidlitz J, Sponheim C, Perkins P, Ungerleider LG, Glen D, Messinger A.A comprehensive macaque fMRI pipeline and hierarchical atlas. NeuroImage. 2021;235:Article 117997.
75.
Ganzetti M, Wenderoth N, Mantini D.Whole brain myelin mapping using T1- and T2-weighted MR imaging data. Front Hum Neurosci. 2014;8:671.
76.
Hartig R, Glen D, Jung B, Logothetis NK, Paxinos G, Garza-Villarreal EA, Messinger A, Evrard HC.The subcortical atlas of the rhesus macaque (SARM) for neuroimaging. NeuroImage. 2021;235:Article 117996.
77.
Weissenbacher A, Kasess C, Gerstl F, Lanzenberger R, Moser E, Windischberger C.Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies. NeuroImage. 2009;47(4):1408–1416.
78.
Wang J, Wang X, Xia M, Liao X, Evans A, He Y.GRETNA: A graph theoretical network analysis toolbox for imaging connectomics. Front Hum Neurosci. 2015;9:386.
79.
Telesford QK, Simpson SL, Burdette JH, Hayasaka S, Laurienti PJ.The brain as a complex system: Using network science as a tool for understanding the brain. Brain Connect. 2011;1(4):295–308.
80.
Wang J, Wang L, Zang Y, Yang H, Tang H, Gong Q, Chen Z, Zhu C, He Y.Parcellation-dependent small-world brain functional networks: A resting-state fMRI study. Hum Brain Mapp. 2009;30(5):1511–1523.
81.
Bolger AM, Lohse M, Usadel B.Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120.
82.
Kim D, Langmead B, Salzberg SL.HISAT: A fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–360.
83.
Liao Y, Smyth GK, Shi W.featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930.
84.
Love MI, Huber W, Anders S.Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
85.
Huang da W, Sherman BT, Lempicki RA.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
Year 2026 volume 9 Issue 9
PDF
66
36
Cite this Article
BibTeX
Article Info
doi: 10.34133/research.1424
  • Receive Date:2026-02-08
  • Online Date:2026-10-16
  • Published:2026-09-20
Article Data
Affiliations
History
  • Received:2026-02-08
  • Revised:2026-08-05
  • Accepted:2026-08-16
Affiliations
    1State Key Laboratory of Genetic Evolution and Animal Models, Yunnan Key Laboratory of Animal Models and Human Disease Mechanisms, and Yunnan Engineering Center on Brain Disease Models, Kunming, Yunnan 650204, China.
    2National Research Facility for Phenotypic & Genetic Analysis of Model Animals (Primate Facility) and National Resource Center for Non-Human Primates, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650107, China.
    3Kunming College of Life Sciences, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China.
    4State Key Laboratory of Cognitive Science and Mental Health, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
    5College of Life Sciences, University of Chinese Academy of Sciences, Beijing 101408, China.
    6Yunnan Key Laboratory of Biodiversity Information, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650201, China.
    7School of Life Science and Technology, Shanghai Tech University, Shanghai, China.
    8KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650204, China.

Corresponding:

* Address correspondence to: (P.Z.);
* Address correspondence to: (N.L.);
* Address correspondence to: (J.-H.W.);
* Address correspondence to: (Y.-G.Y.)
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.34133/research.1424
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT